These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 35582854)
1. Impact of the COVID-19 pandemic on England's national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): an interrupted time series analysis (January 2019-February 2021). Alkhameys S; Barrett R Curr Med Res Opin; 2022 Jul; 38(7):1081-1092. PubMed ID: 35582854 [TBL] [Abstract][Full Text] [Related]
2. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493 [TBL] [Abstract][Full Text] [Related]
3. Trends in anticoagulant prescribing: a review of local policies in English primary care. Ho KH; van Hove M; Leng G BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243 [No Abstract] [Full Text] [Related]
5. Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over. Cavillon Decaestecker M; Ferret L; Decaestecker K; Gautier S; Verdun S; Tsogli ES Drugs Aging; 2021 Oct; 38(10):939-950. PubMed ID: 34486094 [TBL] [Abstract][Full Text] [Related]
6. Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting. Afzal S; Zaidi STR; Merchant HA; Babar ZU; Hasan SS J Thromb Thrombolysis; 2021 Aug; 52(2):646-653. PubMed ID: 33666824 [TBL] [Abstract][Full Text] [Related]
7. Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure. Hsieh MT; Liu CH; Lin SH; Lin PY; Chang YM; Wang CM; Chen CH; Sung PS J Am Heart Assoc; 2023 Dec; 12(23):e029979. PubMed ID: 38038171 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke. Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229 [TBL] [Abstract][Full Text] [Related]
9. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis. Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155 [TBL] [Abstract][Full Text] [Related]
10. Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. Staerk L; Fosbøl EL; Lip GYH; Lamberts M; Bonde AN; Torp-Pedersen C; Ozenne B; Gerds TA; Gislason GH; Olesen JB Eur Heart J; 2017 Mar; 38(12):907-915. PubMed ID: 27742807 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation. Norby FL; Alonso A J Comp Eff Res; 2017 Sep; 6(6):549-560. PubMed ID: 28737102 [TBL] [Abstract][Full Text] [Related]
13. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population. Amin A; Keshishian A; Dina O; Dhamane A; Nadkarni A; Carda E; Russ C; Rosenblatt L; Mardekian J; Yuce H; Baker CL J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961 [No Abstract] [Full Text] [Related]
16. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation. Jackevicius CA; Lu L; Ghaznavi Z; Warner AL Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies. Archontakis-Barakakis P; Li W; Kalaitzoglou D; Tzelves L; Manolopoulos A; Giannopoulos S; Giamouzis G; Giannakoulas G; Batsidis A; Palaiodimos L; Ntaios G; Lip GYH; Kokkinidis DG Br J Clin Pharmacol; 2022 Nov; 88(11):4663-4675. PubMed ID: 35853612 [TBL] [Abstract][Full Text] [Related]
19. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration. Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440 [TBL] [Abstract][Full Text] [Related]
20. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation. Kido K; Ngorsuraches S Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]